Table 1

Baseline characteristics (unadjusted) of the Norwegian and New Zealand participants. Participants free of prior CVD.

MenWomen
EuropeanIndianEuropeanIndian
New Zealand cohort
N 63 319999749 0947039
Age (years)55.0 (9.3)47.4 (9.7)58.7 (8.7)52.9 (8.5)
Age range30.0–74.030.0–74.030.0–74.030.0–74.0
TC (mmol/L)5.36 (1.1)5.09 (1.1)5.68 (1.1)5.04 (1.0)
HDL cholesterol (mmol/L1.29 (0.4)1.14 (0.3)1.59 (0.5)1.30 (0.3)
LDL cholesterol (mmol/L)3.3 (1.0)2.9 (1.0)3.4 (1.1)2.8 (0.9)
TC/HDL ratio4.35 (1.3)4.60 (1.3)3.68 (1.1)3.93 (1.1)
SBP (mm Hg)131.5 (16.3)125.3 (16.1)131.6 (17.4)126.1 (17.4)
Diastolic blood pressure (mm Hg)80.5 (10.0)79.1 (10.4)78.8 (9.7)77.4 (9.8)
Hypertension* (%)40344439
Type 2 diabetes† (%)924929
Former smokers (%)196161
Current smokers (%)129101
Family history of CVD‡ (%)1281510
Antihypertensive treatment (%)24263032
Lipid-lowering treatment (%)18271827
Follow-up time (years)2.94 (2.3)2.93 (2.0)2.92 (2.3)2.83 (1.9)